0.98 USD
▲+0.12+4.28%
盘后 0.94 +0.01%
2026-08-03
市值
$13.51M
市盈率
—
EPS
-0.72
股息率
—
52 周区间
0.76 – 2.67
成交量
116.09K
Beta
1.43
目标价
9.00
52W 低 0.7652W 高 2.67
价格走势
公司简介
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment fo...